Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessUBS Revises American Water Works Company, Inc.'s Outlook to Neutral

UBS Revises American Water Works Company, Inc.’s Outlook to Neutral

Add to Favorite
Added to Favorite


UBS upgrades its price target for American Water Works Company, Inc. (NYSE:AWK) from $124 to $139 and shifts its recommendation to Neutral.
American Water’s dividend offerings are highlighted as a key attraction for income investors, despite a modest price change of -0.13% since the year’s start.
American Water’s recent stock performance and solid financial health, with a market capitalization of around $26.4 billion, support UBS’s revised outlook.

UBS’s recent update on American Water Works Company, Inc. (NYSE:AWK), shifting its recommendation to Neutral and raising its price target from $124 to $139, reflects a nuanced view of the company’s prospects. American Water, based in Camden and operating within the Utilities sector, is a significant player in providing water and wastewater services. This adjustment by UBS, as reported by TheFly, suggests a reassessment of American Water’s financial performance and future growth potential.
The focus on American Water as a compelling dividend stock, as highlighted by Zacks Investment Research, complements UBS’s updated stance. Despite a modest price change of -0.13% since the year’s start, American Water’s dividend offerings stand out. Dividends are vital for income investors seeking steady cash flow, and American Water’s ability to provide this, with dividends sometimes accounting for a significant portion of long-term returns, makes it an attractive investment option.
The stock’s recent performance, with a price increase of $1.12 or approximately 0.83%, trading between $134.41 and $135.71, further supports UBS’s revised outlook. Over the past year, AWK’s price has seen fluctuations between $113.34 and $151.22, indicating a stable yet dynamic market presence. With a market capitalization of around $26.4 billion and a trading volume of 1,763,571 shares, American Water demonstrates solid financial health and investor interest.
UBS’s price target adjustment to $139, just above the current trading price, suggests a belief in American Water’s steady growth potential without significant overvaluation concerns. This balanced view, considering both the company’s dividend attractiveness and its market performance, provides investors with a comprehensive analysis of American Water’s investment potential.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Arch Capital Group’s Market Outlook and Financial Performance

Michael Zaremski from Capital One Financial set a price...

Jazz Pharmaceuticals’ Financial and Operational Highlights

Earnings per Share (EPS) of $3.40, missing the estimated...

Clarivate Plc (NYSE:CLVT) Q3 Earnings Overview

Clarivate Plc reported a Q3 EPS of -$0.09128, missing...

Clean Energy Fuels Corp. (NASDAQ: CLNE) Financial Performance Review

Clean Energy Fuels Corp. (NASDAQ:CLNE) reported a revenue of...